Donoghue Forlines’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Sell
6,561
-1,858
-22% -$514K 0.37% 100
2026
Q1
$2.49M Buy
8,419
+2,841
+51% +$844K 0.69% 44
2025
Q4
$1.52M Sell
5,578
-142
-2% -$38.6K 0.47% 66
2025
Q3
$1.55M Sell
5,720
-9,765
-63% -$2.66M 0.48% 67
2025
Q2
$4.27M Buy
15,485
+1,048
+7% +$285K 1.22% 8
2025
Q1
$3.83M Buy
+14,437
New +$3.56M 1.21% 9
2024
Q4
Sell
-5,742
Closed -$1.27M 129
2024
Q3
$1.27M Buy
+5,742
New +$1.19M 0.36% 91
2018
Q1
Sell
-17,275
Closed -$2.52M 151
2017
Q4
$2.52M Buy
+17,275
New +$2.46M 0.19% 109

Other funds holding CME

Donoghue Forlines's CME Position: Q2 2026 in Review

Donoghue Forlines reduced its CME Group (CME) stake by 22% in Q2 2026, selling an estimated $514K and leaving 6,561 shares worth $1.45M. The position accounts for 0.37% of the portfolio, ranked #100.

Donoghue Forlines first reported a position in CME in Q4 2017 and has held it in 8 quarters since. The position peaked at $4.27M in Q2 2025. 1,704 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Donoghue Forlines held 6,561 shares of CME Group worth $1.45M as of Q2 2026.
  • Donoghue Forlines sold 1,858 CME Group shares in Q2 2026, an estimated $514K.
  • CME Group made up 0.37% of Donoghue Forlines's portfolio in Q2 2026, its #100 holding.
  • Donoghue Forlines first reported a position in CME Group in Q4 2017 and has held it in 8 quarters since.
  • Donoghue Forlines's CME Group position peaked at $4.27M in Q2 2025.
  • 1,704 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.